Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Real‐world insights on switching aflibercept dosage for enhanced outcomes in age‐related macular degeneration ( <scp>RISE</scp> ‐ <scp>AMD</scp> ): Safety data
PaperCitations, authors & open-access status
Real‐world insights on switching aflibercept dosage for enhanced outcomes in age‐related macular degeneration ( <scp>RISE</scp> ‐ <scp>AMD</scp> ): Safety data is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2026 year and hybrid oa status.
0
Citations
2026
Year
hybrid
OA Status